Aeris Environmental Ltd (ASX: AEI) Share Price and News

Stang has more than three decades of experience building and managing companies in the healthcare and biotechnology industry in Australia and internationally. His business development and marketing skills have resulted in the commercialisation of intellectual property across global markets. Mr Stang has been the Executive Chairman of unlisted company Lumitron Technologies since 2016. He is member of Risk and Corporate Governance Committee.

Mr Kritzler holds a number of international patents. He is the Technical Director of Novapharm Research (Australia) Pty Ltd. Mr Kritzler has over 40 years of experience in commercial R&D in the areas of pharmaceutical, medical, cosmetic and speciality industrial products. Under his technical direction, Novapharm Research has become a world-leader in infection control science.

Dr Harry has 25 years of experience in executive management of companies in the biotechnology, diagnostic and biopharmaceuticals sectors. Dr Harry is a CEO with experience in growing companies from start-up to commercialisation, and has demonstrated expertise in building high-performing teams, establishing global partnerships, capital raising, investor relations, together with corporate governance and compliance. She is an experienced Non-Executive Director on the Boards of listed and unlisted companies. She is Chair of the Risk and Corporate Governance Committee.

Dr Widin has over 20 years of experience in global consumer goods, consulting and proptech. She has held various marketing, commercial and international management roles in both private and public companies, such as Procter & Gamble (Australia and Europe) and Kellogg (Asia Pac). Dr Widin is an owner of companies supplying facade management and soft services to the commercial real estate market. She has expertise in go-to-market strategy, innovation pipelines and leading cross-functional teams.

-

-

-

-